- CA$2.64bn
- CA$1.96bn
- $1.14bn
- 97
- 61
- 56
- 82
2019 December 29th | 2020 December 27th | 2021 December 26th | 2022 December 25th | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 53 W |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 874 | 852 | 1,002 | 1,181 | 1,141 |
Cost of Revenue | |||||
Gross Profit | 274 | 264 | 274 | 332 | 334 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 719 | 706 | 860 | 1,009 | 960 |
Operating Profit | 155 | 147 | 142 | 172 | 181 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 160 | 148 | 142 | 174 | 200 |
Provision for Income Taxes | |||||
Net Income After Taxes | 118 | 109 | 106 | 128 | 148 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 115 | 106 | 104 | 128 | 148 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 115 | 106 | 104 | 128 | 148 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.77 | 1.64 | 1.6 | 1.98 | 2.29 |
Dividends per Share | |||||
Special Dividends per Share |